PHARMACEUTICALLY ACTIVE COMPOUNDS AS Axl INHIBITORS Russian patent published in 2016 - IPC C07D401/12 C07D401/14 C07D413/12 C07D413/14 C07D417/12 C07D417/14 A61K31/4709 A61P35/00 

Abstract RU 2573834 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to a compound of structural formula (I) possessing inhibitory activity on the TAM family of receptor tyrosine kinases (RTKs). In formula (I) A represents C-R10; B represents C-R11, N; R1, R4 are independently specified in -H, -F, -Cl, -Br, -I, -OH, -NH2, -OCH3, -OC2H5, -OC3H7, -OCH(CH3)2, -NO2, -CHO, -COCH3, -COC2H5, -COC3H7, -O-cyclo-C3H5, -OCH2-cyclo-C3H5, -O-C2H4-cyclo-C3H5, -OCF3, -OC2F5, -CH2F, -CHF2, -CF3, -CH2Cl, -CH2Br, -CH2I, -CH2-CH2F, -CH2-CHF2, -CH2-CF3, -CH2-CH2Cl, -CH2-CH2Br, -CH2-CH2I, cyclo-C3H5, -CH2-cyclo-C3H5, -CH3, -C2H5, -C3H7, -CH(CH3)2, -C4H9, -CH2-CH(CH3)2, -CH(CH3)-C2H5, -C(CH3)3, -CH=CH2, -CH2-CH=CH2, -C(CH3)=CH2, -CH=CH-CH3; R2 are R3 are independently specified in -O-R18, -O-CR73R74-R18, -O-CR73R74-CR75R76-R18, -O-CR73R74-CR75R76-CR77R78-R18, -O-CR73R74-CR75R76-CR77R78-CR79R80-R18; R5 and R6 represent -H; R7, R8, which can be identical or different from each other, represent -H, -F, -Cl, -Br, -I, -CN, -NO2, -CH3, -C2H5, -C3H7, -CH(CH3)2, cyclo-C3H5, -CH2-cyclo-C3H5, -OCH3; R9 represents -H. The radical values D, R10, R11, R18, R73-R80 are presented in the patent claim. The invention also refers to a pharmaceutical composition containing the above compound.

EFFECT: producing the compounds possessing the inhibitory activity on the TAM family of receptor tyrosine kinases (RTKs).

14 cl, 3 tbl, 106 ex

Similar patents RU2573834C2

Title Year Author Number
PYRAZOLOTRIAZINE DERIVATIVES AS SELECTIVE INHIBITORS OF CYCLIN-DEPENDENT KINASES 2013
  • Ajkkhoff Yan
  • Tsishinski Gunter
  • Kokh Uve
RU2645347C2
PYRIDINONE DERIVATIVES AS TISSUE TRANSGLUTAMINASE INHIBITORS 2013
  • Byukhold Kristian
  • Gerlakh Uve
  • Khils Martin
  • Pasternak Ralf
  • Veber Jokhannes
RU2652987C2
1-(4-ISOXAZOLE-5-YL)-1H-PYRAZOLE-1-YL)-2-METHYLPROPANE-2-OL DERIVATIVES AND RELATED COMPOUNDS AS IL-17 AND IFN-GAMMA INHIBITORS FOR TREATMENT OF AUTOIMMUNE DISEASES AND CHRONIC INFLAMMATION 2018
  • Felding, Yakob
  • Kolkhof, Khella
  • Greppel, Manfred
  • Myuler, Rolf Andreas
  • Fitt, Daniel
  • Shevrie, Karin
  • Zaya, Mirko
  • Tasler, Shtefan
RU2785342C2
AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS 2014
  • Deninno Majkl Pol
  • Anderson Kori
  • Konroj Erika Linn
  • Friman Brajan A.
  • Grotenkhejs Peter Diderik Yan
  • Adida-Rua Sara Sabina
  • Kharli Dennis Dzhejms
  • Per Fabris Zhan Denis
  • Silina Alina
  • Yu Dzhonni
  • Chzhou Tszinlan
RU2741810C2
QUINOLINIL-CONTAINING COMPOUND, ITS PHARMACEUTICAL COMPOSITION AND USE 2020
  • Wu, Wei
  • Zhu, Li
  • Yang, Yanqing
  • Hu, Wei
  • Zhang, Hui
  • Dong, Changxin
RU2803116C2
N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDE COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS 2015
  • Dejvi, Rebekka Luiz
  • Edvards, Khannakh Dzhoj
  • Evans, Devid Majkl
  • Khodgson, Sajmon Tinbi
RU2821520C2
MDM2 PROTEIN DESTRUCTORS 2017
  • Wang, Shaomeng
  • Li, Yangbing
  • Yang, Jiuling
  • Aguilar, Angelo
  • Zhou, Bing
  • Hu, Jiantao
  • Xu, Fuming
  • Rej, Rohan
  • Han, Xin
RU2743432C2
N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDE COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS 2015
  • Hodgson, Simon Teanby
  • Evans, David Michael
  • Edwards, Hannah Joy
  • Davie, Rebecca Louise
RU2707870C2
AROMATIC 6,7-DISUBSTITUTED 3-QUINOLINECARBOXAMIDE DERIVATIVES, METHOD FOR PRODUCTION THEREOF (VARIANTS), PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND USE THEREOF IN DRUG MANUFACTURING 2002
  • Larsson Joakim
  • She Peter
RU2281940C2
IMPROVED APELIN RECEPTOR AGONISTS (APJ) AND THEIR USE 2016
  • Runajon, Skot, P.
  • Mejtra, Rengan
  • Narajanan, Sandzhu
  • Tomas, Dzhejms, Barnuell
  • Reder, Kennet, S.
  • Olepu, Srinivas
RU2766148C1

RU 2 573 834 C2

Authors

Shul'Tts-Fademrekht Karsten

Klebl' Bert

Khojdas Aksel'

Kokh Uve

Ajkkhoff Jan

Vol'F Aleksander

Ull'Rikh Aksel'

Dates

2016-01-27Published

2011-08-26Filed